Form D · Biotechnology
Eclipse Diagnostics Inc
Los Angeles, CA · CIK 0001733206
Offering snapshot reported Feb 14, 2019 · SEC filing
- Reported sold
- $57.5K Offering amount: $60K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jan 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2019 | Initial | $57,500 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-332828
WE WILL NOT SELL THE REMAINING AMOUNT IN THIS OFFERING
Source: Form D, filed Feb 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Luka Fajs | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
750 N San Vicente Blvd
Los Angeles, CA, 90069
Los Angeles, CA, 90069